These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7733160)

  • 1. Hemorrhagic bullae as a complication of urokinase therapy for hemodialysis catheter thrombosis.
    Ejaz AA; Aijaz M; Nawab ZM; Leehey DJ; Ing TS
    Am J Nephrol; 1995; 15(2):178-9. PubMed ID: 7733160
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolytic therapy with urokinase.
    Majors DS
    ANNA J; 1996 Dec; 23(6):627-9. PubMed ID: 9069793
    [No Abstract]   [Full Text] [Related]  

  • 3. Urokinase and dialysis therapy.
    Twardowski ZJ
    Kidney Int; 2000 Jan; 57(1):345. PubMed ID: 10712113
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tesio twin catheter system for hemodialysis tunnelized using an echo-guided technique. Retrospective analysis of 210 catheters].
    Ibrik O; Samon R; Roca R; Viladoms J; Mora J
    Nefrologia; 2006; 26(6):719-25. PubMed ID: 17227250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin and urokinase in situ for partial thrombosis of indwelling hemodialysis catheters.
    Baudeau C; Fitte H
    Am J Kidney Dis; 1993 Oct; 22(4):622. PubMed ID: 8213808
    [No Abstract]   [Full Text] [Related]  

  • 6. Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients.
    Fraschini G; Jadeja J; Lawson M; Holmes FA; Carrasco HC; Wallace S
    J Clin Oncol; 1987 Apr; 5(4):672-8. PubMed ID: 3559656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protocol of urokinase infusion and warfarin for the management of the thrombosed haemodialysis catheter.
    Webb A; Abdalla M; Russell GI
    Nephrol Dial Transplant; 2001 Oct; 16(10):2075-8. PubMed ID: 11572900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
    Prescrire Int; 2009 Jun; 18(101):118. PubMed ID: 19637430
    [No Abstract]   [Full Text] [Related]  

  • 9. A femoral vein catheter with immobilized urokinase (UKFC) as an antithrombotic blood access.
    Kitamoto Y; Fukui H; Iwabuchi K; Taguma Y; Monma H; Ishizaki M; Takahashi H; Nakayama M; Sekino H
    ASAIO Trans; 1987; 33(3):136-9. PubMed ID: 3675935
    [No Abstract]   [Full Text] [Related]  

  • 10. Restoring patency of occluded central venous catheters.
    Hurtubise MR; Bottino JC; Lawson M; McCredie KB
    Arch Surg; 1980 Feb; 115(2):212-3. PubMed ID: 7356837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgraft hemorrhage: a serious complication of low-dose thrombolytic therapy.
    Perler BA; Kinnison M; Halden WJ
    J Vasc Surg; 1986 Jun; 3(6):936-8. PubMed ID: 2940380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase therapy for a catheter-related right atrial thrombus and pulmonary embolism in a 2-month-old infant.
    Zureikat GY; Martin GR; Silverman NH; Newth CJ
    Pediatr Pulmonol; 1986; 2(5):303-6. PubMed ID: 3774387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with the double lumen Silastic catheter for hemoaccess.
    Bour ES; Weaver AS; Yang HC; Gifford RR
    Surg Gynecol Obstet; 1990 Jul; 171(1):33-9. PubMed ID: 2163116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosis of tunneled-cuffed hemodialysis catheters: treatment with high-dose urokinase lock therapy.
    Donati G; Colì L; Cianciolo G; La Manna G; Cuna V; Montanari M; Gozzetti F; Stefoni S
    Artif Organs; 2012 Jan; 36(1):21-8. PubMed ID: 21848863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase therapy for thrombosed hemodialysis access grafts.
    Summers S; Drazan K; Gomes A; Freischlag J
    Surg Gynecol Obstet; 1993 Jun; 176(6):534-8. PubMed ID: 8322124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reestablishing patency in an occluded central venous access device.
    Brown LH; Wantroba I; Simonson G
    Crit Care Nurse; 1989 May; 9(5):114-21. PubMed ID: 2805740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy for thrombotic occlusion of long-term intravenous alimentation catheters.
    Glynn MF; Langer B; Jeejeebhoy KN
    JPEN J Parenter Enteral Nutr; 1980; 4(4):387-90. PubMed ID: 6774122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic and acute consequences of a post-dialysis urokinase lock on permanent hemodialysis catheter function.
    Gabutti L; Mosconi E; Pellegrini L; Duchini F; Marone C
    J Nephrol; 2006; 19(2):183-8. PubMed ID: 16736417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extravasation of thrombus into the aortic root: a complication following use of an infusion catheter for intragraft thrombolysis.
    Caputo RP; Cohen DJ; Baim DS; Kuntz RE
    Cathet Cardiovasc Diagn; 1996 Mar; 37(3):263-6. PubMed ID: 8974802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial.
    Haire WD; Deitcher SR; Mullane KM; Jaff MR; Firszt CM; Schulz GA; Schuerr DM; Schwartz LB; Mouginis TL; Barton RP
    Thromb Haemost; 2004 Sep; 92(3):575-82. PubMed ID: 15351854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.